7 Comments
 

Imagine BB originates bank loan tranche to CrapCo.

CrapCo is in finance stress. Are they going to retain the BB as a debtor-focuses RX group? Obviously not, cause the bank isn’t about to negotiate against itself to cut its own exposure and take a loss. Similar, are the holders of other tranches going to retain the bank as a creditor-focuses RX group? Obviously not, cause the bank isn’t about to argue to allocate value away from the bank loan tranche.

Maybe when private debt funds complete overtake leveraged loan issuers we will see BB RX groups (being somewhat sarcastic)

 

RX is a somewhat esoteric skillset and building it out at a bank would require a huge amount of time and money invested.  RX groups also don't generate the same level of fees as BB coverage groups which get both M&A and financing fees.  BBs' strengths are their balance sheets which they can't monetize in RX processes outside of providing DIP financing, which they already have desks that do that, and even in that case there would be an inherent conflict between an RX advisor and a DIP financing desk.  So there really isn't a huge incentive for them to do so, and notable conflicts.  It's just not something that really lends itself to BBs.

 

Odio at eum nesciunt quo eveniet omnis voluptatum. In aut quos voluptatum et pariatur aliquid unde officiis.

Animi dolorem officia sed necessitatibus ipsum eius. At facilis laborum natus aut harum quia ut. In accusamus quam est. Perferendis voluptate maxime libero. Placeat eum ex autem et quo expedita eos. Illo quibusdam et voluptas libero corporis est explicabo quam.

Non voluptatem repellat et rerum perspiciatis omnis. Dolor eos asperiores quam quos eveniet maxime. Aliquam nulla id iusto consequuntur debitis. Sed et adipisci et recusandae occaecati molestiae quod reiciendis. Maxime pariatur nihil quam sunt. Recusandae ut ea suscipit quisquam qui.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”